loader2
Partner With Us NRI

Company details

48.70
53.90
27.00
145.70
6M Return -20.74%
1Y Return 40.69%
Mkt Cap.(Cr) 51.16
Volume 172,800
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 172,800

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 13.69 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 667.97 50,551.69
LAST 3M 35,594.71 31,884.13
LAST 6M 117,845.77 -123,950.38
LAST 12M 211,388.56 -202,835.68

Information

  • About Company
  • Company Info
  • Listing Info
2.98
34.19%
23.9307
0.72%
0.61%
Description
  • Incorporated as a private limited company in Sep.`86, Combat Drugs (CDL) was converted into a public limited company in Jun.`92. The company was promoted by Suchit Mohan Lal and Ajay Karan. CDL came out with a public issue of 23.23 lac equity shares at par aggregating Rs 2.32 cr in Nov.`94. The proceeds of the issue were utilised to part-finance a Rs 3.25-cr project to expand the existing manufacturing facilities for pharmaceutical formulations and to diversify into the manufacture of sterile powder injectables. CDL started commercial production in Jul.`87 on a loan-licence basis. The company acquired a full-fledged manufacturing unit located at Balanagar, Hyderabad, on lease from Fairchild Laboratories and commenced commercial production in Aug.`88. In Jul.`92 the manufacturing activities were shifted to the present leased premises at Kushaiguda, Hyderabad. In this unit various pharmaceutical formulations such as tablets, capsules and liquids are being manufactured. The product range of CDL comprises vital anti-bacterial drugs, antibiotic drugs, anti-inflammatory drugs, haematenic drugs and protein tonic. CDL has developed in-house technology for the manufacture of dispersible and sustained release formulations. The company is exploring the possibilities of exporting its products to Nigeria and West Indies. During the year 1995-96, the expansion programme undertaken by the company was successfully completed and the unit at Yellampet has become operational. During 1996-97, the company has expanded its operations to new areas. It has expanded its product range by introduction of Liquid Orals. The product "HB 2" has been well accepted in the market. The company has also filled its application for obtaining the (c)GMP and WHO GMP Certificate. During the year 1998-99, the Company initiated steps to diversify into information technology. The Company is in the process of taking over the business of M/s. Softech Institute of Information Technology & Software Development, which would function as the Infotech Division of the Company. The Company also proposes to change its name to "Combat Drugs and Softech Limited" so as to justify both the activities of Pharmaceutical Formulations and Information Technology.

Read More

Registered Address

4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2, Hyderabad, Telangana, 500034

Email : info:combatdrugs.in
Website : http://www.combatdrugs.in

Registrar

Venture Capital & Corp. Inv.

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 100
BSE Code : 524752
NSE Code :
Book Closure Date (Month) :
BSE Group : XT
ISIN : INE643N01012

ICICIdirect Decipher Labs Ltd FAQ

You can buy Decipher Labs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Decipher Labs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 18, 2022 04:01 PM the closing price of Decipher Labs Ltd was ₹ 50.65.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 18, 2022 04:01 PM, the market cap of Decipher Labs Ltd stood at ₹ 51.16.
The latest PE ratio of Decipher Labs Ltd as of Aug 18, 2022 04:01 PM is 2.98
The latest PB ratio of Decipher Labs Ltd as of Aug 18, 2022 04:01 PM is 0.49
The 52-week high of Decipher Labs Ltd is ₹ 145.70 while the 52-week low is ₹ 27.00 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE